Intelligent Bio Solutions (INBS) Equity Ratio (2020 - 2025)

Intelligent Bio Solutions' Equity Ratio history runs 6 years deep, the most recent figure standing at 0.36 for Q2 2025.

• In Q2 2025, Equity Ratio fell 38.85% year-over-year to 0.36; the TTM figure through Jun 2025 stood at 0.36 (down 38.85% YoY), while the FY2025 annual figure was 0.36, down 38.85% from the prior year.
• Equity Ratio was 0.36 for Q2 2025 at Intelligent Bio Solutions, down from 0.52 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.91 in Q1 2021 to a low of 0.14 in Q3 2023.
• Historically, Equity Ratio has averaged 0.54 across 5 years, with a median of 0.54 in 2022.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio slumped 72.21% in 2023, then jumped 256.98% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.66 in 2021, then slipped by 13.75% to 0.57 in 2022, then tumbled by 37.16% to 0.36 in 2023, then soared by 35.46% to 0.48 in 2024, then dropped by 24.97% to 0.36 in 2025.
• The last three Equity Ratio figures came in at 0.36 (Q2 2025), 0.52 (Q1 2025), and 0.48 (Q4 2024), per Business Quant data.